A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Clinical trial NCT05647954 · UNKNOWN

Trial details

NCT number: NCT05647954
Sponsor: Taizhou Hanzhong biomedical co. LTD
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms

Start date: 2022-12-31
Primary completion: 2024-12-30
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.